Clinical Trial: Validation of the Sentinel Lymph Node Technique in Early-stage Ovarian Cancer (SENTOV II)

U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT06963268) titled 'Validation of the Sentinel Lymph Node Technique in Early-stage Ovarian Cancer (SENTOV II)' on April 30.

Brief Summary: This clinical trial investigates the sentinel lymph node (SLN) technique as a less invasive alternative to conventional lymphadenectomy in patients with early-stage ovarian cancer. The primary objective is to evaluate the effectiveness, safety, and diagnostic accuracy of the SLN approach in detecting lymphatic metastases. By assessing its negative predictive value, the study aims to determine whether the SLN technique can reliably replace systematic pelvic and paraaortic lymphadenectomy. If successful, this technique ...